The work required of the clinical microbiology laboratory Given the rapid changes in nosocomial pathogens, in medical care, and in health care delivery, staff members from the laboraand of the infection control program has become increasingly complex, demanding, and intertwined as the decade of the tory and from infection control must collaborate continuously and must communicate openly. The relationship between the 1990s has progressed. To do their jobs effectively and efficiently, these two groups must work as a team, using the expermicrobiology laboratory and the infection control program is critical to the success of both groups. In this review we discuss tise from each discipline to improve patient care. As in the past, the microbiology laboratory must be able to detect and the microbiology laboratory's role in this essential collaboration. identify microorganisms so that the clinicians can diagnose and treat established infections and the infection control team can monitor, prevent, and control infections in the hospital environment.
The work required of the clinical microbiology laboratory Given the rapid changes in nosocomial pathogens, in medical care, and in health care delivery, staff members from the laboraand of the infection control program has become increasingly complex, demanding, and intertwined as the decade of the tory and from infection control must collaborate continuously and must communicate openly. The relationship between the 1990s has progressed. To do their jobs effectively and efficiently, these two groups must work as a team, using the expermicrobiology laboratory and the infection control program is critical to the success of both groups. In this review we discuss tise from each discipline to improve patient care. As in the past, the microbiology laboratory must be able to detect and the microbiology laboratory's role in this essential collaboration. identify microorganisms so that the clinicians can diagnose and treat established infections and the infection control team can monitor, prevent, and control infections in the hospital environment.
The Clinical Microbiologist and the Infection Control Committee However, the number and types of pathogens that the laboratory must detect have increased dramatically. New technology,
The clinical microbiologist, or the microbiology supervisor developed to detect, identify, and characterize microorganisms, in an institution without a doctoral level microbiologist, is an has improved significantly the laboratory's ability to keep up integral part of the infection control team and thus must be an with the rapidly changing nosocomial pathogens. In particular, active member of the infection control committee. Because the molecular biological techniques have enhanced the speed and infection control committee frequently bases its decisions on sensitivity of detection methods and have allowed the laborathe results of microbiological tests, the clinical microbiologist tory to identify organisms that do not grow or grow slowly in must teach the committee how to interpret culture results and culture. Molecular biological techniques also enable the microwhich microbiological approaches could be used to solve spebiologist to identify antibiotic-resistance genes and to ''fingercific infection control problems. Furthermore, the microbioloprint'' hospital organisms, thereby facilitating studies of nosogist must explain the resources necessary to accomplish the comial transmission.
committee's goals. Conversely, while serving on the commitIn addition to performing their traditional roles, albeit with tee, the microbiologist will learn about the problems confrontnew tools, laboratory personnel must perform some tasks that ing hospital epidemiology and infection control personnel and are specifically designed to facilitate infection control activities.
thus will be better able to organize the laboratory's response For example, the laboratory should also participate actively in to such problems. surveillance efforts, and laboratory staff members should help
The microbiologist must educate the committee about sevplan and execute microbiological and molecular epidemiologieral important issues. Because most infection control personnel cal investigations of nosocomial infections. The laboratory staff have not worked in laboratories, the microbiologist will need also must provide the infection control team with high-quality to ensure that these individuals understand basic microbiology data in a timely fashion and teach the infection control personprinciples and techniques. The microbiologist must also explain nel how to use laboratory resources appropriately during epidethe advantages and limitations, the scope and adequacy (i.e., miological investigations. sensitivity and specificity), and the costs of microbiological The clinical microbiologist (doctoral level microbiologist, methods used to detect, identify, and assess the antimicrobial pathologist, microbiology supervisor, or designated laboratory susceptibility of the most common nosocomial pathogens. personnel), hospital epidemiologist (or infectious disease clini-
In addition, the microbiologist should inform the committee cian), and infection control professional must work as a team about changes in methods, reagents, or instrumentation that to prevent and control nosocomial infections effectively [1] . may substantially affect the laboratory's ability to detect and characterize nosocomial pathogens. Because most laboratories have limited financial and staff resources, the microbiologist must help the infection control staff and the committee under-be enhanced if the infection control staff members regularly seriousness of needlestick injuries or other exposures and determine whether prophylaxis is warranted. Recently, detection of make rounds in the laboratory to ask questions, review microbiological and molecular epidemiological results, and discuss HCV RNA by PCR, coupled with genotyping of the virus, was useful in defining the epidemiology of an outbreak of HCV current problems and issues. Likewise, the microbiology staff should attend conferences at which infection control personnel infection among recipients of human intravenous immunoglobulin [18] . discuss epidemiological principles and contemporary topics.
Accurate Identification of Nosocomial Pathogens Automated Identification and Susceptibility Testing
The clinical laboratory's ability to identify nosocomial In many instances, the results of routine culture and identification procedures are the first indications that patients have pathogens accurately is challenged continuously by the expanding spectrum of organisms that colonize and infect seriacquired nosocomial infections. For most epidemiological investigations, the routine procedures performed in the microbiolously ill patients. Pathogens such as Staphylococcus aureus, Staphylococcus epidermidis, enterococci, Candida albicans, ogy laboratory are satisfactory. However, in selected instances, certain laboratory services and expertise, which may extend and the Enterobacteriaceae, which are easy to detect and identify, cause most nosocomial infections. However, an array of beyond routine practice and knowledge, may be necessary. Regardless of which tests are performed, the laboratory must unusual or fastidious pathogens also cause nosocomial infections. Current examples include bacteria such as Acinetobacter perform the tests quickly, accurately, and reproducibly to ensure that the infection control team can identify and assess species, Burkholderia cepacia, and Stenotrophomonas maltophilia; fungi such as Aspergillus species, non-albicans spenosocomial infections properly.
cies of Candida, Fusarium species, and Pneumocystis carinii; viruses such as respiratory syncytial virus, rotavirus, and
Rapid Diagnostic Tests
cytomegalovirus; and parasites such as Cryptosporidium, Cyclospora, and Microsporidium species. Consequently, the The increased repertoire of immunologic and molecular methods has enhanced the ability of the microbiology laboradiagnostic microbiology laboratory frequently must update the methods used to identify and characterize pathogens. In additory to detect a variety of bacteria, fungi, and protozoa [2 -5] . Investigators have used a variety of molecular biological tion, the laboratory staff must read and attend conferences to enhance their knowledge. techniques, including nucleic acid probe hybridization, target amplification, and signal-generating formats, to detect pathoMost microbiology laboratories can isolate organisms from clinical material, identify isolates to species level, and perform genic microorganisms directly in clinical specimens (table 1) [6 -13] . The most widely used method amplifies the target antimicrobial susceptibility testing. The classic manual methods of identification and susceptibility testing have largely been DNA by PCR. The newer amplification technologies such as ligase chain reaction and transcription-mediated amplification replaced by automated or semiautomated commercial systems that use frozen or dried microdilution panels [14] . Currently, will form the basis of additional diagnostic systems that are or are soon likely to be available for use in the clinical laboratory semiautomated or fully automated microbiology systems are available in a variety of formats, including instruments that (table 1) .
The clinical microbiologist, in consultation with appropriate perform only identification or testing of susceptibility to antimicrobial agents and instruments that can identify the organism clinicians and members of the infection control team, should determine whether the laboratory should perform rapid microand test its susceptibility to antimicrobial agents simultaneously. Automated systems can test common aerobic and faculbiological tests. The group should base the decision on data in the literature, data generated by their laboratory (if possible), tative gram-negative and gram-positive bacterial pathogens and also anaerobes and fastidious organisms such as Neisseria, and data on their patient population. In addition, the group should try to determine whether the test would improve patient Haemophilus, and Moraxella species and yeasts [19 -21] . The commercial identification and antimicrobial susceptibilcare substantially. In this era of competition and cost-consciousness, such critical evaluations have become even more ity testing systems offer several advantages over the older, manual methods. First, the commercial systems have standardimportant than they were previously [14 -17] .
A critical review of the literature indicates that most existing ized the performance and interpretation of microbiological tests among various laboratories. Second, the instruments have simmolecular diagnostic tests are of limited or no use for infection control purposes. However, rapid and sensitive amplificationplified many tedious, labor-intensive steps. Third, systems that use photometric or fluorometric technology assess results more based methods that detect Mycobacterium tuberculosis in sputum specimens may be very important tools for infection rapidly and objectively than do manual methods. Fourth, commercial microbiology systems can perform tests more reprocontrol. Likewise, molecular methods for detection and characterization of HIV and hepatitis C virus (HCV) might help ducibly than their conventional counterparts [19 -21] , and fifth, compared with the conventional methods, the accuracy of the infection control and employee-health staff quickly assess the / 9c3d$$oc52 09-18-97 20:28:35 cida UC: CID automated and semiautomated identification and susceptibility cocci are resistant to oxacillin [31, 34] , and Enterobacteriaceae are resistant to b-lactam drugs [19] . Conversely, some highly testing systems is 90% -95% [19 -24] .
The newer methods allow laboratories to perform a wider automated systems falsely identify certain gram-negative bacilli as being resistant to agents such as imipenem and aztreovariety of tests than they could with manual methods, thereby decreasing the number of specimens that must be sent to refernam [25] . The combination of these problems (false susceptibility and false resistance) could cause the infection control team ence laboratories. On-site microbiological testing is clearly an advantage when the infection control program must investigate to direct their efforts away from true problems and toward spurious problems. nosocomial infections because the results can be obtained quickly and the isolates are available in the laboratory if addiBecause automated systems have serious limitations and because new pathogens and resistance mechanisms evolve, many tional tests are necessary.
Despite their advantages, the commercial microbiology syslaboratories supplement the automated systems with additional manual susceptibility tests such as disk diffusion, agar dilution, tems may have significant limitations that are especially relevant with regard to infection control [19] . The limitations are broth dilution, or the new stable gradient technology (Etest, AB BIODISK, Solna, Sweden), all of which have performed most prominent among the systems that use short (3-to 5-hour) incubation periods to decrease the time needed for satisfactorily for many of the problematic organism-drug combinations [27, 33, 35, 36] . For example, at the University of testing antimicrobial susceptibility [25 -31] . These systems can misclassify organisms that display heteroresistance to b-lactam Iowa we employ the Vitek System (bioMerieux, Hazelwood, MO) for susceptibility testing of Enterobacteriaceae, a microdiantibiotics, have inducible resistance mechanisms, or have high mutation rates in the genes controlling susceptibility because lution broth panel for testing gram-positives and nonenteric gram-negative bacilli (e.g., Acinetobacter, Pseudomonas, and their resistance phenotype might become apparent only after an incubation period longer than 3 -5 hours.
Stenotrophomonas species), and Etest for testing fastidious organisms such as Streptococcus pneumoniae. Thus, many commercial systems underestimate the frequency with which pneumococci are resistant to penicillin [27] ,
The rapid automated identification systems appear to make fewer errors than do antimicrobial susceptibility testing sysenterococci are resistant to glycopeptides [ Naturally occurring vancomycin-resistant strains of S. aureus tems that employ longer incubation times have similar problems identifying certain organisms [21] .
have not been described. However, vancomycin-resistant isolates of Staphylococcus haemolyticus, enterococci, and other less common Finally, automated microbiology systems are often useful for routine testing. However, they inherently lack flexibility gram-positive cocci have been obtained from clinical specimens (table 2) [33, 39, 40, 50, 53] . VRE, particularly Enterococcus and, thus, these systems might hinder infection control efforts. Consequently, microbiology laboratories must be able to implefaecium, are epidemic in many centers [33, 50, 54] , and nosocomial bloodstream infections caused by these organisms have an exment less automated and more labor-intensive testing if the clinical and epidemiological evidence indicates that these methtremely high attributable mortality [55] .
The mechanism of resistance to vancomycin in S. haemolytiods are warranted. Hence, the microbiologist constantly must consider whether techniques in addition to those used for roucus and other nonenterococcal gram-positive cocci is chromosomally encoded and is unrelated to the plasmid-mediated resistine testing will enhance the infection control efforts.
tance in E. faecium and Enterococcus faecalis [56] . Because the vancomycin-resistance gene in those enterococcal species Emerging Pathogens and Antimicrobial Resistance is on a transmissible element, many microbiologists and epidemiologists are concerned that VRE might transmit this gene to In recent years, gram-positive cocci and Candida species have replaced gram-negative bacilli as the most common causes staphylococci [43] . In addition, strains of enterococci that are resistant to b-lactam antibiotics, aminoglycosides, and vancoof nosocomial infections [38 -42] . For example, the frequency of infections caused by E. coli has declined and the frequency mycin have become widespread [33, 50] . Thus, multiresistant enterococci can be a reservoir for resistance genes that can be of infections caused by staphylococci (coagulase-negative staphylococci and S. aureus), enterococci, and C. albicans has transferred to other organisms [56] . Multiresistant enterococci are easily transmitted in hospitals increased [39, 43] . Serious infections caused by streptococci (S. pneumoniae and viridans group streptococci) and Mycobacbecause they frequently contaminate the rooms where the patients are housed. Furthermore, no currently available antimiterium species have also become quite common [44 -48] .
One of the more alarming recent trends has been the increascrobial agent or combination of agents has bactericidal activity against the multiresistant enterococci. Consequently, these oring frequency with which resistant pathogens are causing nosocomial infections. Even among species that are usually suscepganisms present a major challenge to clinicians and to infection control personnel. To help control the spread of multiresistant tible, the strains causing nosocomial infections are often resistant to agents in more than one antimicrobial class [43] .
enterococci, clinical microbiology laboratories might need to participate in active surveillance for these organisms. Such Thus, the infection control team must track not only antibioticresistant gram-negative pathogens but also quinolone and methsurveillance could be limited to obtaining full susceptibility profiles on all enterococci obtained from normally sterile body icillin resistance in staphylococci, multiple antibiotic resistance in enterococci, penicillin resistance in pneumococci and other sites but could also involve conducting either point prevalence or routine stool culture surveys on high-risk units to identify streptococci, vancomycin resistance in gram-positive cocci, and polyene and azole resistance in Candida and other fungal resistant enterococci. Regardless of their approach to controlling resistant enteropathogens (table 2) [33, 40, 41, 49 -52] .
The microbiology laboratory's role in monitoring resistance cocci, microbiologists and the infection control staff must remember that many automated systems detect resistant enterois extremely important to the success of the infection control effort. Laboratory personnel must notify infection control staff cocci poorly. Although most automated systems are capable of detecting high-level (van A -mediated) resistance to vancoimmediately when resistant organisms are identified and when new or unusual phenotypic resistance patterns are found so that mycin, many have difficulty detecting the van B -containing strains [32] . Thus, the laboratory must supplement the autoappropriate isolation precautions can be instituted.
Methicillin-resistant strains of S. aureus and coagulase-negamated systems with appropriate manual methods to ensure that these important nosocomial pathogens are identified and that tive staphylococci have long been recognized as important nosocomial pathogens; however, their numbers are increasing. An inducible chromosomal type I cephalosporinase that con-S. pneumoniae and of the viridans group streptococci have become resistant to cephalosporins, macrolides, and trimethofers resistance to almost all b-lactam drugs, including thirdgeneration cephalosporins and b-lactamase-inhibitor combinaprim-sulfamethoxazole. The laboratory should perform appropriate susceptibility tests so that these multiresistant strains tions, can be produced by strains of Enterobacter, Citrobacter, and Serratia species, indole-positive Proteus species, and can be identified promptly. Laboratory staff should notify the clinicians and the infection control staff immediately upon de-P. aeruginosa that carry the amp C gene. The Amp C b-lactamase is not normally produced at high concentrations, tection of multiresistant strains of S. pneumoniae so that the patient receives effective therapy and spread of the organisms but production of the enzyme can be induced when the organisms are exposed to the newer cephalosporins, resulting in can be prevented.
Despite the significant increase in the frequency of nosocomial strains that are resistant to numerous antimicrobial agents [66] . Enterobacter species can become resistant to newer cephaloinfections caused by gram-positive organisms, gram-negative bacilli as a group remain frequent and important causes of sporins while the patient is receiving therapy. These organisms may become resistant when a mutation permanently ''switches nosocomial infections [39] . In addition to the enteric bacilli and Pseudomonas aeruginosa, other gram-negative organisms such on'' production of the enzyme, eliminating the need for induction. These organisms are called stably derepressed mutants as Acinetobacter species, S. maltophilia, and B. cepacia have become important nosocomial pathogens worldwide [60, 61] .
[64]. Routine testing may indicate that these organisms are suscepMany gram-negative nosocomial pathogens have developed resistance to b-lactam antibiotics through small changes in the tible to newer cephalosporins, but ESBL-and Amp C -producing organisms are not truly susceptible to these agents (e.g., structure of enzymes (usually TEM-1, TEM-3, and SHV-1 b-lactamase enzymes) that they already possess. These novel cefotaxime, ceftriaxone, ceftazidime, and cefoperazone). In addition, many in vitro susceptibility assays used in the clinical extended-spectrum b-lactamases (ESBLs) are increasing in frequency among Klebsiella species and other Enterobacteriaceae microbiology laboratory do not detect resistance unless the organism has been induced or the enzyme production is deresuch as Escherichia coli and Citrobacter species, and have been identified most frequently in teaching hospitals and intenpressed. In particular, rapid (3-to 5-hour incubation) automated or semiautomated methods and microdilution assays in which sive care units [62] . The ESBLs are located on transmissible plasmids and may be present with other resistance factors, a relatively low inoculum of organism (10 5 cfu/mL) is tested are prone to make these very serious errors. resulting in multiresistant pathogens [40, 63] . Organisms that produce ESBLs can disseminate easily in units that use broad-
The laboratory must use a macrodilution broth method (1-to 5-mL total volume), an agar disk diffusion method, the Etest, spectrum cephalosporins extensively. In some cases, a single Infection control staff members need the microbiological data generated routinely by the laboratory to do their job. Thus, cfu/mL) and an incubation time of 18 -24 hours to correctly identify organisms that carry these resistance determinants. If they usually review microbiology reports daily. However, infection control personnel who limit their interaction with the such strains are identified, the laboratory must undertake surveillance to determine the extent to which these organisms laboratory to phone conversations and computer screens or printouts will miss much of what the laboratory can offer. have spread within the hospital [39, 67]. Such laboratory-based surveillance compliments the efforts of the infection control Infection control personnel who visit frequently in the laboratory will not only gather important data efficiently but also program to prevent person-to-person spread and the efforts of the pharmacy committee to limit antibiotic use and thus limit establish relationships that will be critical during crisis times such as outbreaks. Laboratory rounds enable the infection conthe selection of such strains.
Finally, fungal pathogens, such as Candida species, Tritrol team to clarify whether patients are colonized or infected, ensure that specimens from epidemiological investigations are chosporon beigelii, and Fusarium and Aspergillus species, have become important nosocomial pathogens. Consequently, estabevaluated properly, and focus the laboratory's efforts such that infection control issues are addressed optimally. lished antifungals such as amphotericin B are used more frequently and newer classes of antifungal agents such as the The microbiology laboratory must store the data it generates so that aggregate data can be analyzed to establish the fretriazoles, lipid formulations of amphotericin B, and echinocandin derivatives have been introduced [42, 49, 68] . Standardized quency with which specific organisms cause infection and to allow infection control personnel to assess trends or patterns in antifungal susceptibility testing methods [69] programs. However, certain information that traditionally was saved on laboratory work cards (e.g., the results of specific Furthermore, extensive use of triazole antifungals (e.g., fluconazole) for prophylaxis and therapy has been associated in biochemical reactions and the morphological features of the colony) may not be retained and thus will be unavailable for some institutions with the emergence of azole-resistant strains of C. albicans and with an increasing number of infections epidemiological investigations [1] . The microbiologist and the infection control staff should review which information is caused by Candida krusei and Candida glabrata, which are inherently more resistant to these antifungal agents [42, 49, stored so that the needs of the infection control program are met and the resources of the microbiology laboratory are used 71]. Two recent outbreaks caused respectively by a strain of C. albicans resistant to fluconazole [72] and a strain of wisely. Periodic summaries of selected microbiology results may be C. lusitaniae resistant to amphotericin B and 5-fluorocytosine [73] should warn microbiologists and infection control personquite useful to both clinicians and infection control staff. A table or pie graph that illustrates the frequency with which nel that multiresistant strains of Candida may develop and spread within the hospital environment. particular nosocomial pathogens are isolated from specific sites and the antimicrobial susceptibility profiles of these organisms Microbiology laboratories in hospitals caring for patients at high risk of fungal infections may need to conduct surveillance will help clinicians choose appropriate empirical therapy and will allow the microbiologist and the infection control staff to to detect such organisms and prevent outbreaks. To this end, clinical microbiology laboratories may need to expand their follow trends in nosocomial pathogens and antibiotic resistance within the hospital [74] . ability to identify yeasts to the species level [49] .
When developing this report the microbiologist should exclude the results of repeated cultures performed for the same patient and yielding the same organism so that the data are not Reporting Laboratory Data biased. In addition, the hospital's efforts to save money might be enhanced if the cost of each antimicrobial agent is listed in The laboratory should report all results as quickly as possible. In most situations, routine reporting on the hospital's comthe report. puter or on paper will be adequate for clinical and epidemiological purposes. However, the results of some cultures or tests Role of the Microbiology Laboratory in Outbreak have a higher priority than others because they will affect the Investigation patient's care substantially or because they require an immediate response by the infection control staff. Examples of results
The microbiology laboratory often serves as an ''early warning'' system [1], by identifying clusters of organisms with that must be reported immediately include positive cultures of blood and normally sterile body fluids, smears and cultures unique phenotypic characteristics and communicating the observations promptly to infection control personnel. When conpositive for acid-fast bacilli, cultures yielding enteric pathogens such as Salmonella or Shigella species, and cultures that yield fronted with a cluster or outbreak of nosocomial infections, the infection control team must act quickly to characterize and multiply resistant organisms.
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09-18-97 20:28:35 cida UC: CID define the extent of the outbreak, to identify possible causes, It is important to emphasize that the laboratory should not undertake any epidemiological investigation without prior conand to design and implement effective control measures (table 3) [1]. Members of the infection control team must comsultation with the hospital epidemiologist or infection control professional. The practice of ''ad hoc'' epidemiological municate clearly with each other during outbreaks to ensure that the investigation proceeds quickly and efficiently and to workup by physicians and nurses who are not part of the infection control team, while well-meaning, is inefficient, wasteful, ensure that all affected persons are identified and the specimens are processed appropriately. Given the stress inherent in an and possibly more confusing than useful in controlling nosocomial infections. outbreak investigation and the speed with which important decisions must be made, the infection control team, including Staff members in both the infection control program and the laboratory have important unique responsibilities during laboratory personnel, might need to meet daily to discuss new findings and make decisions.
outbreak investigations. One of the laboratory's critical responsibilities is to save all potentially relevant organisms in case Outbreak investigations can be facilitated if the infection control team prepares in advance. One step in this process is further analysis is needed. Regardless of their ability to perform special tests to characterize the organisms, all microbiology to identify the most common types of outbreaks that have occurred in the hospital (e.g., S. aureus wound infections in laboratories should save isolates during outbreaks. If the laboratory cannot do necessary tests, the isolates can be sent to a the surgical intensive care unit or VRE bacteremia on the liver transplant service). Laboratory and infection control personnel reference laboratory. Similarly, the laboratory should save all organisms that might be even remotely related to the outbreak, can then determine what resources (e.g., personnel, time, money, materials, space, or special tests) would be required to because organisms can be discarded if they are not needed but cannot be retrieved once they have been thrown away. investigate a ''typical'' outbreak. The infection control team and the administration should determine in advance how to pay the extra costs associated with outbreak investigation so Supplementary Cultures that squabbles over priorities or financing do not impair important investigations. The excess costs should not be charged During the course of an epidemiological investigation, the microbiology laboratory might be asked to perform specialized to the affected patients, nor should these costs be paid from the laboratory's operating budget.
or supplementary cultures of specimens from patients, hospital (table 3) . Before processing hunthat the cultures are warranted, or because the results are needed for a research project or for an important educational program dreds of specimens, the infection control and laboratory staff must review the epidemiological data, their previous experi- [67, 80] . ence, and the literature to determine which tests are necessary for the specific investigation.
Epidemiological Typing
Special culture media might improve the laboratory's ability to identify the reservoir. For example, selective media (i.e.,
The laboratory characterization of nosocomial pathogens to provide evidence regarding their biological and genetic relatwhich inhibits the growth of species other than that of interest) or differential media (i.e., which reveals distinctive morphologedness is frequently useful to epidemiologists as an aid in the investigation of nosocomial infections. In many situations, ical features that differentiate the species of interest from other species), or both, might allow staff members to process specispecies identification and antimicrobial susceptibility testing can determine whether the isolates are epidemiologically remens expeditiously and to reduce their work. In addition, enrichment cultures might be necessary to optimize the laboratolated. If a cluster of nosocomial infections is caused by an organism such as E. coli, S. epidermidis, or P. aeruginosa ry's ability to detect specific nosocomial pathogens (e.g., Candida [75] or methicillin-resistant staphylococci [76] ) presthat is a frequent or universal member of the normal flora or environment, additional tests might be required to determine ent in low numbers.
The etiologic agent's primary reservoir and mode of transwhether the isolates are related. Subspecies delineation or strain or subtype identification is done to determine whether various mission will determine whether cultures of specimens from hospital personnel, medical devices, and the hospital enviisolates yield the same or different results in one or more tests. If isolates from different patients yield the same result ronment (e.g., surfaces, air, or water) are necessary (table  3) . Cultures of infusion-related products and devices (e.g., or ''fingerprint,'' the isolates probably originated from a single clone and were transmitted from patient to patient from a comblood products, parenteral fluids, and intravascular devices), environmental surfaces, disinfectants, respiratory therapy mon source or by a common mechanism [83 -86] . Similarly, if the same strain or subtype of an organism is repeatedly equipment, air, water, and ice rarely provide useful information when done in the absence of epidemiological data impliisolated from a single patient, the organism most likely is infecting or colonizing the patient and is unlikely to be a concating a source [1, 77] .
Because the hands of hospital personnel can transfer nosocotaminant. Epidemiological typing methods include both phenotypic mial pathogens from patient to patient, cultures using the brothbag method [75, 78] may help confirm the hypothesis that (traditional and protein-based) and genotypic (DNA-based) methods (table 4) . Phenotypic methods such as antimicrobial the etiologic agent was spread in this manner [79 -81] . These specialized cultures should be performed rarely and only when susceptibility profiles, biochemical profiles, bacteriophage susceptibility patterns, multilocus enzyme electrophoresis profiles, epidemiological evidence suggests that a particular person or object might have transmitted the epidemic strain. In rare circumstances, cultures of specimens from personnel or the environment could either save time and effort for the team or In contrast with many of the phenotypic methods, genotypic typing methods can be used with only minor modifications in techniques for epidemiological typing [83 -86] .
Investigators have used a variety of DNA-based methods to equipment, reagents, or procedures to assess a wide variety of bacterial, fungal, viral, and protozoan species [95] . In general, genotype nosocomial pathogens (tables 4 and 5). All of these methods use electric fields to separate DNA -either restriction the DNA-based methods are relatively simple to perform and give highly reproducible results that are stable over time [83, endonuclease digestion fragments, amplified DNA fragments, or whole chromosomes or plasmids -into unique patterns or 84]. These methods are capable of identifying a large number of polymorphisms, and most methods have been tested to deter-''fingerprints'' that are visualized by staining the DNA with ethidium bromide or by nucleic acid probe hybridization. Epimine whether they can distinguish epidemiologically related from unrelated isolates [83 -85, 94] . demiologically related isolates share the same DNA profile or ''fingerprint'' pattern, whereas epidemiologically unrelated DNA-based typing methods have enabled investigators to study the relationship between colonizing and infecting isolates isolates have distinctly different patterns.
In addition to identifying ''gross fingerprints,'' molecular in individual patients [96, 97] [84, 85] . Several excellent and comprehensive reviews provide more ceptibility tests [93] . These methods might also allow clinicians to choose antibiotic therapy that would be least likely to select detailed information on each technique and discuss the practical applications, strengths, and weaknesses of each test [83 -85] . resistant organisms, given the isolates' genetic background.
Furthermore, these methods enhance the ability of the microAll laboratory tests have limitations, and the genotypic typing methods are no exception to this rule. Microbiologists and biologist and the infection control personnel to track the spread of specific resistance genes within and among health care faciliinfection control staff members who want to use these tech- NOTE. This list is not all-inclusive but includes genotyping methods used in epidemiological studies. * PCR is frequently used to amplify a gene relevant to antimicrobial resistance, which must be characterized by other methods such as DNA sequence analysis or single-strand conformational polymorphism analysis to determine if a gene mutation that confers resistance is present.
niques as tools for epidemiological investigations must underPulsed-field gel electrophoresis and certain PCR-based typing methods perform well for a wide array of nosocomial pathostand these limitations so that they do not misinterpret the test results. The DNA patterns generated by these techniques are gens and are the molecular typing methods most frequently used to investigate nosocomial infections. However, as aptly often highly complex and quite difficult to analyze. Thus, investigators must become well-versed in the basic principles of stated by Maslow and Mulligan, the best method for a given epidemiological situation is the one that works [84] . Despite molecular biology and epidemiology and must learn the art of reading the patterns.
theoretical or actual limitations, many typing methods work quite well when used in the context of a careful epidemiological Computer-assisted systems can help investigators compare complex banding patterns [107] ; however, these systems still investigation [84, 86] . In contrast, if investigators use the most powerful and sophisticated typing methods indiscriminately in require the user to do considerable editing. Problems with DNA extraction and digestion or differences in the conditions of the absence of sound epidemiological data, these techniques may provide conflicting and confusing information. amplification (PCR-based methods) or electrophoresis can cause variations in the final profile, further complicating the analysis of DNA banding patterns. Consequently, two or more Summary and Conclusions isolates can be compared only if they were typed under identi-
The clinical microbiology laboratory is an essential compocal conditions. The laboratory ideally should use one test run nent of an effective infection control program. Laboratory perto assess all isolates that must be compared.
sonnel have a broad range of technologies, from traditional Finally, the methodology, nomenclature, and reference methods of detecting and identifying organisms to modern mostrains have not been standardized, a limitation which can imlecular typing methods, that they can use to support and enpede the interpretation and comparison of results obtained by hance the efforts of the infection control staff. If the infection different methods or different laboratories [108] . Flexible and control team applies these technologies appropriately, it can sophisticated computer-based analysis systems such as Denprevent problems and solve nosocomial mysteries efficiently. dron (Solltech, Iowa City, IA) and fully automated molecular
In this era of cost-containment, staff members in the laboratory typing systems such as the RiboPrinter (Qualicon, Wilmington, and in the infection control program must work hard to commu-DE) are major steps toward standardization and quantitative nicate their unique and shared goals, needs, and problems. If analysis of molecular typing results [105, 107, 109] . In addithe laboratory and infection control personnel cooperate and tion, groups of investigators have begun developing standards collaborate rather than compete, both programs will be successand guidelines for the use of DNA-based typing methods, but ful and the patients and the hospital will benefit because the more work must be done in this area [108 -110] .
risk of nosocomial infections and the frequency of resistant Molecular epidemiological typing methods allow microbiolorganisms will be reduced. ogists and the infection control staff to identify specific strains within a given species, which in turn allows the team to study the epidemiology of nosocomial pathogens and then develop
